Intriguingly, the use of MLN4924, a specific neddylation inhibitor that forms a stable MLN4924-NEDD8 adduct by binding to NEDD8, has been shown to decrease lipid accumulation by suppressing SREBP1 neddylation in liver cancer cells [71]. The gene discussed is NEDD8; the disease is liver cancer.